THIRDLAW MOLECULAR

We have developed a novel chemical platform of synthetic, modular, fused-ring structures with a diverse range of functional groups, allowing us exquisite control of their molecular shapes. Using this platform, ThirdLaw Molecular is designing and synthesizing libraries of billions of unique, elegantly structured, chemically diverse compounds for highly selective binding of proteins of biologic interest... ThirdLaw Molecular LLC was founded in 2020 by Christian Schafmeister, Ph.D., Professor of Chemistry at Temple University, to advance his research into synthetic alternatives to proteins and develop an entirely new platform for targeted drug discovery. He is joined by a team of passionate innovators in pursuit of this mission... ThirdLaw Molecular LLC has pioneered the development of Spiroligomer™ molecules and is developing this innovative, patent-protected, therapeutic modality into a new class of more targeted medicines. The mission of the Company is to create a revolutionary..

Also known as: Thirdlaw Molecular LLC

Primary location: Blue Bell United States